Prosecution Insights
Last updated: April 19, 2026

Ontario Institute For Cancer Research (Oicr)

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17630304 MOLECULAR CLASSIFIERS FOR PROSTATE CANCER GRAY, JESSICA 1682 Non-Final OA Jan 26, 2022
17618248 UNSATURATED HETEROCYCLOALKYL AND HETEROAROMATIC ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF STONEBRAKER, ALYSSA RAE 1642 Final Rejection Dec 10, 2021
17612695 PAN-CANCER TRANSCRIPTIONAL SIGNATURE SISSON, BRADLEY L 1682 Non-Final OA Nov 19, 2021

Managing Ontario Institute For Cancer Research (Oicr)'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month